(Q43563910)

English

A prospective, open-label treatment trial to compare the effect of IFN beta-1a (Avonex), IFNbeta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis

scientific article published in March 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

A prospective, open-label treatment trial to compare the effect of IFN beta-1a (Avonex), IFNbeta-1b (Betaseron), and glatiramer acetate (Copaxone) on the relapse rate in relapsing-remitting multiple sclerosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

multiple sclerosis

0 references

author name string

O A Khan

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

A C Tselis

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

J A Kamholz

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

J Y Garbern

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

R A Lewis

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

R P Lisak

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

publication date

1 March 2001

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

European Journal of Neurology

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

141-148

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00189.X

21 January 2018

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00189.X

21 January 2018

Incidence of exacerbations in the first 90 days of treatment with recombinant human interferon beta-1b in patients with relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00189.X

21 January 2018

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00189.X

21 January 2018

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00189.X

21 January 2018

Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00189.X

21 January 2018

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00189.X

21 January 2018

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2001.00189.X

21 January 2018

Identifiers

10.1046/J.1468-1331.2001.00189.X

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43563910&oldid=2101120432"